Crohn's Disease
"I was in the original FDA FK506 study as a pre-transplant patient (Primary Sclerosing Cholangitis ).  I had been given 6 yrs to have a liver transplant.  My liver #&#039;s were 3-4 digits and I was becoming very ill.  My dosage was stabilized at 3 mgs and my numbers have decreased to normal.  I have been on this medicine since 10 &#039;92 and still no transplant.  The medicine has slowed the progress of PSC drastically.  I see it is used for Crohn&#039;s, but nothing is listed for liver diseases.  Did they ever evaluate the trial results from the early 90&#039;s?   My current insurance will not approve the drug for me for this reason.  This might be the result of the trial www.ncbi.nlm.nih.gov/pmc/articles/PMC2982698/ or is a similar one."